These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9522840)

  • 1. Progress in the management of Alzheimer's disease.
    Smith AL; Whitehouse PJ
    Hosp Pract (1995); 1998 Mar; 33(3):151-4, 157-66. PubMed ID: 9522840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the treatment of Alzheimer's.
    Richter RW; Farlow MR
    J Okla State Med Assoc; 1998 Nov; 91(8):431-7. PubMed ID: 9828525
    [No Abstract]   [Full Text] [Related]  

  • 3. New therapeutic approaches to cognitive impairment.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development.
    Cutler NR; Sramek JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jan; 25(1):27-57. PubMed ID: 11263756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
    Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
    ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future therapeutic approaches to Alzheimer's disease.
    Davis KL
    J Clin Psychiatry; 1998; 59 Suppl 11():14-6. PubMed ID: 9731545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.
    Senin U; Cherubini A; Palumbo B; Mecocci P
    Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Alzheimer's disease].
    López OL; Becker JT
    Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic approaches to Alzheimer's disease.
    Schneider LS
    J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease. Cholinergic therapy and beyond.
    Sunderland T
    Am J Geriatr Psychiatry; 1998; 6(2 Suppl 1):S56-63. PubMed ID: 9581222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Curr Drug Targets; 2012 Apr; 13(4):483-94. PubMed ID: 22280345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review).
    Cai Z
    Mol Med Rep; 2014 May; 9(5):1533-41. PubMed ID: 24626484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Alzheimer's disease.
    Mayeux R; Sano M
    N Engl J Med; 1999 Nov; 341(22):1670-9. PubMed ID: 10572156
    [No Abstract]   [Full Text] [Related]  

  • 15. Alzheimer's disease: early diagnosis and treatment.
    Chu LW
    Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
    Doraiswamy PM
    CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the drug treatment of Alzheimer's disease.
    Sramek JJ; Cutler NR
    Drugs Aging; 1999 May; 14(5):359-73. PubMed ID: 10408736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Int Rev Neurobiol; 2011; 100():191-215. PubMed ID: 21971009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
    Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
    J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and therapy of Alzheimer's disease: what's important for the family doctor?].
    Perneczky R; Kurz A
    MMW Fortschr Med; 2008 Dec; 150(49-50):42-5; quiz 46. PubMed ID: 19133370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.